Search Results - For the BLOOM Study Group
- Showing 1 - 2 results of 2
-
1
Impact of Various Estimated Glomerular Filtration Rate Equations on the Pharmacokinetics of Meropenem in Critically Ill Adults by Erin F. Barreto, PharmD, MSc, Jack Chang, PharmD, MSc, Andrew D. Rule, MD, Kristin C. Mara, MSc, Laurie A. Meade, RN, Johar Paul, RRT, Paul J. Jannetto, PhD, Arjun P. Athreya, PhD, Marc H. Scheetz, PharmD, MSc, For the BLOOM Study Group
Published in Critical Care Explorations (2023-12-01)Get full text
Article -
2
Impact of Extending Beta-Lactam Infusions on IV Access Requirements by Kirstin J. Kooda, PharmD, Julia Nelson, BS, Sara E. Ausman, PharmD, Christina G. Rivera, PharmD, Omar M. Abu Saleh, MBBS, Andrew D. Rule, MD, Ryan W. Stevens, PharmD, Micaela N. Warfield, PharmD, Yanjun Zhao, PharmD, Erin F. Barreto, PharmD, PhD, on behalf of the Beta Lactam Optimization and Outcomes Management (BLOOM) Study Group, Laura M. Dinnes, PharmD, Ognjen Gajic, MD, Laurie A. Meade, RN, Rebecca J. Wessel, DPT, MBA.
Published in Critical Care Explorations (2025-08-01)Get full text
Article
